Total Funding
67
15
Total FundingSeries A raised
Growth Score
-7 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
876530
Hemosphere is a commercial medical device company specialized in vascular access for patients on dialysis.
- Fred Lampropoulos: Chairman and Chief Executive OfficerPast Role: Merit Medical Systems, Chief Executive Officer
Sue Horvath: CFO & Vice President, Operations & Human Resources
About the Company
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction.
